Targeted Therapeutics in CLL and MCL: Applying Emerging BTK Inhibitor Therapy Data to Practice *

Get up to date on emerging data with BTK inhibitors for chronic lymphocytic leukemia and mantle cell lymphoma presented at the 2023 EHA, ICML, SOHO, and ESMO meetings with expert podcasts, downloadable slides, text modules, an infographic, and an on-demand webcast. 

Share

Program Content

No activities added yet

No activities added yet

No activities added yet

No activities added yet

No activities added yet

No activities added yet

No activities added yet

No activities added yet

No activities added yet

No activities added yet

Provided by

ProCE Banner

Provided by Clinical Care Options, LLC

Supporters

Supported by an educational grant from Lilly.

Lilly

*ProCE is an independent medical education company that provides state-of-the-art medical information to healthcare professionals through conference coverage and other educational programs.